A. Buzyn

P. Chevallier, I. Yakoub-Agha, D. Blaise, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic and syngeneic hematopoietic cell transplantation in patients with amyloid light-chain amyloidosis: a report from the European Group for Blood and Marrow Transplantation.

H. Goldschmidt, N. Kröger, S. Iacobelli, 2006, Blood.

Hematological malignancy associated with polymyositis and dermatomyositis.

Z. Amoura, J. Ménard, P. Cacoub, 2012, Autoimmunity reviews.

PREDICTING THE COSTS OF ALLOGENEIC SIBLING STEM-CELL TRANSPLANTATION: RESULTS FROM A PROSPECTIVE, MULTICENTER, FRENCH STUDY

S. Chevret, F. Roudot-thoraval, I. Durand-zaleski, 2004, Transplantation.

Reflections on gut decontamination in hematology.

C. Cordonnier, A. Buzyn, C. Tancrède, 1999, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Membrane-bound Fas (Apo-1/CD95) ligand on leukemic cells: A mechanism of tumor immune escape in leukemia patients.

J. Estaquier, J. Guillet, J. Ameisen, 1999, Blood.

Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Sociéte Française de Greffe de Moelle et de Thérapie Cellulaire

J. Bourhis, M. Labopin, I. Yakoub-Agha, 2010, Leukemia.

Changes in intensive care for allogeneic hematopoietic stem cell transplant recipients

S. Chevret, A. Moreau, É. Azoulay, 2015, Bone Marrow Transplantation.

Therapeutic Drug Monitoring of Posaconazole: a Monocentric Study with 54 Adults

D. Lebeaux, C. Elie, O. Lortholary, 2009, Antimicrobial Agents and Chemotherapy.

Modifications in phospholipase D activity and isoform expression occur upon maturation and differentiation in vivo and in vitro in human myeloid cells

A. Buzyn, B. Geny, V. Montalescot, 2000, Leukemia.

Long-term renal function after allogenic haematopoietic stem cell transplantation in adult patients: a single-centre study.

C. Elie, A. Buzyn, F. Fakhouri, 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Evidence for anti-tumour effect of allogeneic haematopoietic SCT in cases without sustained donor engraftment

M. Robin, E. Deconinck, P. Tiberghien, 2010, Bone Marrow Transplantation.

Urinary tract obstruction due to extramedullary plasmacytoma: report of two cases

B. Arnulf, A. Buzyn, F. Fakhouri, 2009, NDT plus.

Hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: experience of the French neutropenia registry

A. Fischer, J. Casanova, G. Leverger, 2005, Bone Marrow Transplantation.

Comparison of Outcomes After Allogeneic HSCT for Adult Patients with AML in Remission Using in the Conditioning Regimen Either I.V. Busulfex (BU) Plus Cyclophosphamide (Cy) or TBI Plus Cy: An- ALWP-EBMT Survey.

M. Labopin, A. Nagler, L. Volin, 2009 .

Coronavirus 229E-Related Pneumonia in Immunocompromised Patients

A. Cariou, F. Pène, P. Lebon, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Disseminated Scopulariopsis brevicaulis infection in an allogeneic stem cell recipient

D. Bouscary, A. Buzyn, A. Paugam, 2011, Bone Marrow Transplantation.

Performance of Serum Biomarkers for the Early Detection of Invasive Aspergillosis in Febrile, Neutropenic Patients: A Multi-State Model

B. Farley, A. Vekhoff, S. Leprêtre, 2013, PloS one.

Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Ce

J. Bourhis, I. Yakoub-Agha, J. Golmard, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Epidemiology and risk factors for gram-positive coccal infections in neutropenia: toward a more targeted antibiotic strategy.

R. Leclercq, C. Cordonnier, A. Buzyn, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Société Française de Greffe de Moelle (SFGM)

A. Baruchel, H. Tilly, D. Blaise, 2000, Bone Marrow Transplantation.

Clinical spectrum and long-term follow-up of 14 cases with G6PC3 mutations from the French severe congenital neutropenia registry

C. Picard, M. Frémond, J. Bruneau, 2014, Orphanet Journal of Rare Diseases.

IFN Regulatory Factor-2 Cooperates with STAT1 to Regulate Transporter Associated with Antigen Processing-1 Promoter Activity1

I. Dusanter-Fourt, A. Buzyn, M. Rouyez, 2005, The Journal of Immunology.

STAT 1 to Regulate Transporter Associated IFN Regulatory Factor-2 Cooperates with

I. Dusanter-Fourt, A. Buzyn, M. Rouyez, 2005 .

Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports.

J. Mira, É. Azoulay, F. Pène, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Real-time blood plasma polymerase chain reaction for management of disseminated adenovirus infection.

C. Rouzioux, E. Abachin, S. Blanche, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1/FBXW7 mutations, but not of low ERG/BAALC expression: a GRAALL study.

H. Dombret, E. Macintyre, S. Leprêtre, 2011, Blood.

Prognostic and oncogenic relevance of TLX1/HOX11 expression level in T-ALLs.

J. Soulier, E. Clappier, H. Dombret, 2007, Blood.

Analysis of TCR, pT alpha, and RAG-1 in T-acute lymphoblastic leukemias improves understanding of early human T-lymphoid lineage commitment.

E. Macintyre, F. Davi, P. Quartier, 2003, Blood.

T-ALLs Prognostic and oncogenic relevance of TLX1/HOX11 expression level in

J. Soulier, E. Clappier, H. Dombret, 2013 .

Medical Immunology Fadd Adaptor in Cancer the Fadd Molecule

A. Buzyn, L. Tourneur, G. Chiocchia, 2022 .

lymphoblastic leukemia: a LALA-94 study Impact of TCR status and genotype on outcome in adult T-cell acute

J. Cayuela, H. Dombret, E. Macintyre, 2013 .

Impact of TCR status and genotype on outcome in adult T-cell acute lymphoblastic leukemia: a LALA-94 study.

J. Cayuela, H. Dombret, E. Macintyre, 2005, Blood.

Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial

H. Dombret, A. Stamatoullas, A. Delannoy, 2007, Leukemia.

Results of a prospective phase 2 study combining imatinib mesylate and cytarabine for the treatment of Philadelphia-positive patients with chronic myelogenous leukemia in chronic phase.

M. Tulliez, P. Berthaud, P. Rousselot, 2003, Blood.

Ex Vivo Characterization of Multiepitopic Tumor-Specific CD8 T Cells in Patients with Chronic Myeloid Leukemia: Implications for Vaccine Development and Adoptive Cellular Immunotherapy1

L. Saveanu, L. Camoin, F. Guilhot, 2005, The Journal of Immunology.

Adoptive Cellular Chronic Myeloid Leukemia : Implications for Tumor-Specific CD 8 T Cells in Patients with Ex Vivo Characterization of Multiepitopic

L. Saveanu, L. Camoin, F. Guilhot, 2005 .

CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRγδ lineage

E. Macintyre, X. Troussard, C. Charrin, 2003 .

CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRgammadelta lineage.

E. Macintyre, X. Troussard, C. Charrin, 2003, Blood.

Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia.

J. Cayuela, H. Dombret, E. Macintyre, 2014, Blood.

Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial.

H. Dombret, A. Stamatoullas, A. Delannoy, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intensified Therapy of Acute Lymphoblastic Leukemia in Adults: Report of the Randomized GRAALL-2005 Clinical Trial.

H. Dombret, E. Macintyre, S. Leprêtre, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study.

H. Dombret, E. Macintyre, A. Delannoy, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis and/or at first relapse: results from the GET-LALA group.

H. Dombret, A. Stamatoullas, A. Delannoy, 2007, Leukemia research.

Rescue therapy combining intermediate-dose cytarabine with amsacrine and etoposide in relapsed adult acute lymphoblastic leukemia.

A. Stamatoullas, A. Delannoy, C. Gardin, 2004, The Hematology Journal.

Allogeneic stem cell transplantation for agnogenic myeloid metaplasia: a European Group for Blood and Marrow Transplantation, Société Française de Greffe de Moelle, Gruppo Italiano per il Trapianto del Midollo Osseo, and Fred Hutchinson Cancer Research Center Collaborative Study.

H. Deeg, J. Anderson, A. Bacigalupo, 1999, Blood.

Equal access to innovative therapies and precision cancer care

J. Blay, G. Vassal, D. Pérol, 2016, Nature Reviews Clinical Oncology.

Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia.

N. Schmitz, D. Hasenclever, A. Nagler, 2002, Blood.

Decreased nonrelapse mortality after unrelated cord blood transplantation for acute myeloid leukemia using reduced-intensity conditioning: a prospective phase II multicenter trial.

S. Chevret, P. Chevallier, I. Yakoub-Agha, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Rapamycin for Refractory Acute Graft-Versus-Host Disease

O. Hermine, F. Suarez, A. Buzyn, 2009, Transplantation.

Prediction of relapse by day 100 BCR-ABL quantification after allogeneic stem cell transplantation for chronic myeloid leukemia

F. Davi, V. Asnafi, A. Buzyn, 2006, Leukemia.

Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation

H. Dombret, A. Stamatoullas, A. Vekhoff, 2000, Leukemia.

Second early allogeneic stem cell transplantations for graft failure in acute leukaemia, chronic myeloid leukaemia and aplastic anaemia

D. Blaise, J. Reiffers, M. Tanguy, 2000, British journal of haematology.

Double umbilical cord blood transplantation for hematological malignancies: a long-term analysis from the SFGM-TC registry.

M. Robin, I. Yakoub-Agha, D. Blaise, 2013, Experimental hematology.

Budesonide/Formoterol for bronchiolitis obliterans after hematopoietic stem cell transplantation.

S. Chevret, M. Robin, E. Bergot, 2015, American journal of respiratory and critical care medicine.

Post-allogeneic haematopoietic stem cell transplantation membranous nephropathy: clinical presentation, outcome and pathogenic aspects.

B. Knebelmann, C. Combe, F. Glowacki, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Allogeneic bone marrow transplantation for agnogenic myeloid metaplasia

H. Tilly, N. Ifrah, H. Esperou, 1997 .

Double reduced-intensity allogeneic hematopoietic stem cell transplantation: a retrospective study from the SFGM-TC.

M. Robin, P. Chevallier, D. Blaise, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic stem cell transplantation improves the outcome of adults with t(1;19)/E2A-PBX1 and t(4;11)/MLL-AF4 positive B-cell acute lymphoblastic leukemia: results of the prospective multicenter LALA-94 study

H. Dombret, A. Delannoy, J. Gabert, 2006, Leukemia.

Tax unleashed: fulminant Tax-positive Adult T-cell Leukemia/Lymphoma after failed allogeneic stem cell transplantation.

Yuetsu Tanaka, A. Renand, O. Hermine, 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Autologous stem-cell transplantation in patients with mantle cell lymphoma beyond 65 years of age: a study from the European Group for Blood and Marrow Transplantation (EBMT).

H. Tilly, C. Crawley, P. Biron, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Low nonrelapse mortality and prolonged long-term survival after reduced-intensity allogeneic stem cell transplantation for relapsed or refractory diffuse large B cell lymphoma: report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire.

M. Robin, I. Yakoub-Agha, M. Mohty, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Donor lymphocyte infusions for the treatment of chronic myeloid leukemia relapse following peripheral blood or bone marrow stem cell transplantation

W. Wiktor-Jedrzejczak, T. Witte, G. Gurman, 2013, Bone Marrow Transplantation.

Early posttransplantation donor-derived invariant natural killer T-cell recovery predicts the occurrence of acute graft-versus-host disease and overall survival.

M. Cavazzana‐Calvo, P. Milpied, O. Hermine, 2012, Blood.

Hypereosinophilia as a presenting sign of acute graft-versus-host disease after allogeneic bone marrow transplantation

N. Brousse, J. Emile, G. Damaj, 2002, Transplantation.

Serum monoclonal component and nephrotic syndrome--it is not always amyloidosis. Diagnosis: WM complicated by retroperitoneal and renal infiltration and associated with a minimal change disease.

Benjamin Deroure, A. Buzyn, B. Terrier, 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Toward a NOTCH1/FBXW7/RAS/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.

B. Nadel, H. Dombret, E. Macintyre, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia--results of the prospective multicenter LALA-94 trial.

J. Bourhis, J. Cayuela, H. Dombret, 2002, Blood.

Induction of NKG2D ligands by gamma radiation and tumor necrosis factor-alpha may participate in the tissue damage during acute graft-versus-host disease.

N. Brousse, M. Cavazzana‐Calvo, V. Soumelis, 2008, Transplantation.

Autologous peptides eluted from acute myeloid leukemia cells can be used to generate specific antileukemic CD 4 helper and CD 8 cytotoxic T lymphocyte responses in vitro

D. Fradelizi, J. Guillet, A. Buzyn, 2005 .

Outcome of patients with T-cell lymphoblastic leukemia or lymphoma: The GRAALL experience

H. Dombret, E. Macintyre, S. Leprêtre, 2007 .

Early post-transplant donor-derived invariant natural killer T cell recovery predicts the occurrence of acute graft-versus-host disease and overall survival Running head : iNKT cells in human allogeneic

M. Cavazzana‐Calvo, P. Milpied, O. Hermine, 2012 .

Fludarabine Plus Cyclophosphamide and Rituximab (RFC) in Waldenström’s Macroglobulinemia (WM): Results in 21 Patients (pts).

V. Leblond, S. Choquet, B. Mahé, 2006 .

Fludarabine Plus Cyclophosphamide and Rituximab In Waldenström's Macroglobulinemia: Results In 55 Patients

J. Tamburini, C. Gardin, A. Delmer, 2010 .

Allogeneic bone marrow transplantation for agnogenic myeloid metaplasia. French Society of Bone Marrow Transplantation.

H. Tilly, N. Ifrah, H. Esperou, 1997, British journal of haematology.

High‐dose CD34+ cells are not clinically relevant in reducing cytopenia and blood component consumption following myeloablative therapy and peripheral blood progenitor cell transplantation as compared with standard dose

R. Porcher, O. Hermine, A. Buzyn, 2002, Transfusion.

Combined treatment with arsenic trioxide and all-trans-retinoic acid in patients with relapsed acute promyelocytic leukemia.

H. Dombret, P. Rousselot, H. de Thé, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hierarchical Evaluation of Baseline Poor-Prognosis Factors and Response to Initial Therapy in Younger Adults with Ph-Negative Acute Lymphoblastic Leukemia (ALL) Treated in the Risk-Adapted GRAALL-2003 Study.

H. Dombret, E. Macintyre, A. Delannoy, 2005 .

Treatment of Philadelphia-Positive Acute Lymphocytic Leukemia (Ph+ ALL) in the Elderly with Imatinib Mesylate (STI571) and Chemotherapy.

H. Dombret, E. Macintyre, A. Delannoy, 2005 .

T-cell prolymphocytic leukemia with autoimmune manifestations in Nijmegen breakage syndrome

I. Radford‐Weiss, A. Buzyn, B. Varet, 2003, Annals of Hematology.

The Upper Age Limit for a Pediatric-Inspired Therapy in Younger Adults with Ph-Negative Acute Lymphoblastic Leukemia (ALL)? Analysis of the Graall-2005 Study

H. Dombret, E. Macintyre, S. Leprêtre, 2016 .

Results of the AFR07 Prospective Study in De Novo Philadelphia Positive ALL Patients Aged over 55 Years: Efficacy and Safety of a Glivec® Based Induction Followed by Maintenance Therapy with Glivec® and Pegasys®.

J. Cayuela, H. Dombret, C. Récher, 2007 .

Towards a Pediatric Approach in Adults with Acute Lymphoblastic Leukemia (ALL): The GRAALL-2003 Study.

H. Dombret, E. Macintyre, A. Delannoy, 2006 .

Risk factors for Gram-negative bacterial infections in febrile neutropenia.

R. Leclercq, C. Cordonnier, A. Buzyn, 2005, Haematologica.

NOTCH1/FBXW7 Mutation Identifies a Large Subgroup with Favorable Outcome in Adult T-ALL: A GRAALL Study.

H. Dombret, E. Macintyre, M. Béné, 2008 .

Aging and cancer - addressing a nation's challenge.

A. Buzyn, J. Bréchot, M. Le Quellec-Nathan, 2013, Interdisciplinary topics in gerontology.

Listeria monocytogenes skin infection with cerebritis and haemophagocytosis syndrome in a bone marrow transplant recipient.

P. Berche, A. Buzyn, C. Poyart, 2005, The Journal of infection.

Late-onset neutropenia following rituximab results from a hematopoietic lineage competition due to an excessive BAFF-induced B-cell recovery.

X. Mariette, N. Casadevall, V. Soumelis, 2007, Haematologica.

THE LONG-TERM OUTCOME OF ELDERLY PATIENTS WITH PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH plus ALL) IN THE IMATINIB ERA

H. Dombret, A. Delannoy, M. Béné, 2009 .

Absence or Low Expression of Fas-Associated Protein with Death Domain in Acute Myeloid Leukemia Cells Predicts Resistance to Chemotherapy and Poor Outcome

E. Macintyre, O. Legrand, I. Radford‐Weiss, 2004, Cancer Research.

Resistance to Chemotherapy and Poor Outcome Death Domain in Acute Myeloid Leukemia Cells Predicts Absence or Low Expression of Fas-Associated Protein with Updated

E. Macintyre, O. Legrand, I. Radford‐Weiss, 2004 .

Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for Patients Aged ≥60 Years: a Retrospective Study of 629 Patients From the Societe Française De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC).

P. Chevallier, I. Yakoub-Agha, D. Blaise, 2009 .

[High risk of cardiac dysfunction after treatment of secondary acute myeloid leukemia following chemotherapy and radiotherapy for breast cancer].

E. Messas, O. Hermine, A. Fourquet, 2010, Bulletin du cancer.

Coexistence and Parallel Evolution of Hypereosinophilic Syndrome, Autoimmune Hepatitis, and Ulcerative Colitis Suggest Common Pathogenic Features

O. Hermine, F. Suarez, H. Fontaine, 2007, The American Journal of Gastroenterology.

Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome – positive acute lymphoblastic leukemia : results of the GRAAPH-2003 study

J. Cayuela, H. Dombret, E. Macintyre, 2007 .

Autologous stem-cell transplantation in patients with mantle cell lymphoma beyond 65 years of age: a study from the European Group for Blood and Marrow Transplantation (EBMT).

H. Tilly, C. Crawley, P. Biron, 2012 .

Outcome of Treatment after First Relapse in Adults Patients with Acute Lymphoblastic Leukemia (ALL) Initially Treated by the LALA-94 Trial.

A. Stamatoullas, A. Delannoy, J. Gabert, 2006 .

Vaccination in adults with auto-immune disease and/or drug related immune deficiency: results of the GEVACCIM Delphi survey.

J. Pouchot, X. Mariette, E. Hachulla, 2009, Vaccine.

Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome – positive acute lymphoblastic leukemia : results of the GRAAPH-2003 study

J. Cayuela, H. Dombret, E. Macintyre, 2007 .

Interest of Non-Myeloablative Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma: A Multicenter Retrospective Study.

I. Yakoub-Agha, A. Nagler, M. Mohty, 2008 .

Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study.

J. Cayuela, H. Dombret, E. Macintyre, 2007, Blood.

Is There Still a Place for Total Body Irradiation (TBI) In the Conditioning Regimen of Autologous Stem Cell Transplantation In Mantle Cell Lymphoma ?: a Retrospective Study From the Lymphoma Working Party of the EBMT

H. Tilly, D. Blaise, C. Crawley, 2010 .

Allogeneic stem cell transplantation (allo-SCT) in T-cell lymphomas: A French national survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)

C. Volteau, D. Blaise, N. Ifrah, 2007 .

Prognostic Significance of Complement System Activation After Allogeneic Hematopoietic Stem Cell Transplantation.

W. Fridman, P. Milpied, O. Hermine, 2009 .

Adverse prognostic significance of CD20 expression in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia

H. Dombret, N. Ifrah, A. Buzyn, 2010, Haematologica.